About Index Trending news
Analyze
Top 50 Pricing
Ambit Biosciences

Ambit Biosciences

Work at Ambit Biosciences? Add yourself to this profile

Ambit Biosciences

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

Elsewhere

Alexa global traffic share

06 Nov 2012
$50,000,000
Venture capital
10 Jun 2011
$30,000,000
Venture capital (Series D)
12 May 2005
$31,000,000
Venture capital (Series C)